Literature DB >> 15215138

Proteomic analysis of azole resistance in Candida albicans clinical isolates.

Massoumeh Z Hooshdaran1, Katherine S Barker, George M Hilliard, Harald Kusch, Joachim Morschhäuser, P David Rogers.   

Abstract

Changes in protein expression within a matched set of Candida albicans isolates representing the acquisition of azole resistance were examined by two-dimensional polyacrylamide gel electrophoresis and peptide mass fingerprinting. Proteins differentially expressed in association with azole resistance included Grp2p, Ifd1p, Ifd4p, Ifd5p, and Erg10p, a protein involved in the ergosterol biosynthesis pathway.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15215138      PMCID： PMC434221          DOI： 10.1128/AAC.48.7.2733-2735.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  25 in total

1.  Genomic profiling of the response of Candida albicans to itraconazole treatment using a DNA microarray.

Authors:  M D De Backer; T Ilyina; X J Ma; S Vandoninck; W H Luyten; H Vanden Bossche
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Population genomics of drug resistance in Candida albicans.

Authors:  Leah E Cowen; André Nantel; Malcolm S Whiteway; David Y Thomas; Daniel C Tessier; Linda M Kohn; James B Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-27       Impact factor: 11.205

3.  Molecular aspects of fluconazole resistance development in Candida albicans.

Authors:  R Franz; M Ruhnke; J Morschhäuser
Journal:  Mycoses       Date:  1999       Impact factor: 4.377

4.  A common drug-responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance.

Authors:  Michelle de Micheli; Jacques Bille; Christoph Schueller; Dominique Sanglard
Journal:  Mol Microbiol       Date:  2002-03       Impact factor: 3.501

5.  The effects of transcription regulating genes PDR1, pdr1-3 and PDR3 in pleiotropic drug resistance.

Authors:  A Nawrocki; S J Fey; A Goffeau; P Roepstorff; P M Larsen
Journal:  Proteomics       Date:  2001-08       Impact factor: 3.984

6.  Evaluation of differential gene expression in fluconazole-susceptible and -resistant isolates of Candida albicans by cDNA microarray analysis.

Authors:  P David Rogers; Katherine S Barker
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

7.  Mitochondrial DNA instability mutants of the bifunctional protein Ilv5p have altered organization in mitochondria and are targeted for degradation by Hsp78 and the Pim1p protease.

Authors:  Joseph M Bateman; Michelina Iacovino; Philip S Perlman; Ronald A Butow
Journal:  J Biol Chem       Date:  2002-10-14       Impact factor: 5.157

Review 8.  Resistance of human fungal pathogens to antifungal drugs.

Authors:  Dominique Sanglard
Journal:  Curr Opin Microbiol       Date:  2002-08       Impact factor: 7.934

9.  Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains.

Authors:  R Franz; S L Kelly; D C Lamb; D E Kelly; M Ruhnke; J Morschhäuser
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

Review 10.  The genetic basis of fluconazole resistance development in Candida albicans.

Authors:  Joachim Morschhäuser
Journal:  Biochim Biophys Acta       Date:  2002-07-18
View more
  16 in total

1.  Transcriptional profiling of azole-resistant Candida parapsilosis strains.

Authors:  A P Silva; I M Miranda; A Guida; J Synnott; R Rocha; R Silva; A Amorim; C Pina-Vaz; G Butler; A G Rodrigues
Journal:  Antimicrob Agents Chemother       Date:  2011-04-25       Impact factor: 5.191

2.  Non-glucan attached proteins of Candida albicans biofilm formed on various surfaces.

Authors:  Govindsamy Vediyappan; W Lajean Chaffin
Journal:  Mycopathologia       Date:  2006-01       Impact factor: 2.574

3.  Changes in the proteome of Candida albicans in response to azole, polyene, and echinocandin antifungal agents.

Authors:  Christopher F Hoehamer; Edwin D Cummings; George M Hilliard; P David Rogers
Journal:  Antimicrob Agents Chemother       Date:  2010-02-09       Impact factor: 5.191

4.  Proteomic analysis of Mrr1p- and Tac1p-associated differential protein expression in azole-resistant clinical isolates of Candida albicans.

Authors:  Christopher F Hoehamer; Edwin D Cummings; George M Hilliard; Joachim Morschhäuser; P David Rogers
Journal:  Proteomics Clin Appl       Date:  2009-08       Impact factor: 3.494

5.  CaIPF14030 negatively modulates intracellular ATP levels during the development of azole resistance in Candida albicans.

Authors:  Xin-ming Jia; Ying Wang; Jun-dong Zhang; Hong-yue Tan; Yuan-ying Jiang; Jun Gu
Journal:  Acta Pharmacol Sin       Date:  2011-04       Impact factor: 6.150

6.  Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans.

Authors:  Teresa T Liu; Robin E B Lee; Katherine S Barker; Richard E Lee; Lai Wei; Ramin Homayouni; P David Rogers
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

7.  Proteome analysis of Aspergillus ochraceus.

Authors:  Muhammad Rizwan; Ingrid Miller; Fareeha Tasneem; Josef Böhm; Manfred Gemeiner; Ebrahim Razzazi-Fazeli
Journal:  Mycotoxin Res       Date:  2010-03-31       Impact factor: 3.833

8.  Farnesol-induced apoptosis in Candida albicans.

Authors:  Mark E Shirtliff; Bastiaan P Krom; Roelien A M Meijering; Brian M Peters; Jingsong Zhu; Mark A Scheper; Megan L Harris; Mary Ann Jabra-Rizk
Journal:  Antimicrob Agents Chemother       Date:  2009-04-13       Impact factor: 5.191

9.  Typing of genetic markers involved in stress response by fluorescent cDNA-amplified fragment length polymorphism technique.

Authors:  Victoria Levterova; Stefan Panaiotov; Nadia Brankova; Kristin Tankova
Journal:  Mol Biotechnol       Date:  2010-05       Impact factor: 2.695

10.  ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates.

Authors:  Ann R Holmes; Ya-Hsun Lin; Kyoko Niimi; Erwin Lamping; Mikhail Keniya; Masakazu Niimi; Koichi Tanabe; Brian C Monk; Richard D Cannon
Journal:  Antimicrob Agents Chemother       Date:  2008-08-18       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.